Altered expression of genes related to innate antifungal immunity in the absence of galectin-3

Virulence. 2021 Dec;12(1):981-988. doi: 10.1080/21505594.2021.1903212.

Abstract

Galectin-3 (Gal-3) is the most studied member of the animal galectin family, which comprises β-galactoside-binding lectins and participates in several cellular events. Its expression in cells involved in innate and adaptive immunity is related to anti- and proinflammatory functions, signaling an important role in inflammatory, infectious, and tumorigenesis processes. Mice deficient in Gal-3 exhibit important phenotypes, but it is unclear whether these phenotypes reflect an impairment of the functions of this protein. Gal-3 plays an important role in modulating the immune response to different pathogenic microorganisms. However, the role of Gal-3 in immunity to infection is still poorly understood. Therefore, we investigated the effects of Gal-3 deletion on the expression of genes involved in the innate immune response in the lungs, spleens, and brains of Gal-3 KO mice. Gene profiling expression analysis suggested that Gal-3 deletion resulted in differentially modulated expression of the genes encoding beta-glucan, mannose and chitin-responsive pattern recognition receptors, signal transduction, inflammation, and phagocytosis. Our data thus suggest the importance of Gal-3 expression in the host innate immune system.

Keywords: Galectin-3; antifungal immunity; gene expression; gene knockout; innate immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • Animals
  • Antifungal Agents*
  • Galectin 3* / genetics
  • Galectins / genetics
  • Immunity, Innate
  • Mice

Substances

  • Antifungal Agents
  • Galectin 3
  • Galectins

Grants and funding

This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico [420670/2018-1]; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FAEPA); Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [2016/03322-7, 2016/25167-3].